Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HDAC6 as a potential therapeutic target for peripheral nerve disorders

25 Oct 2018

Abstract excerpt

INTRODUCTION: Peripheral neuropathies are a heterogeneous group of diseases that are characterized by a progressive, ascending loss of nerve function arising from the peripheral regions of the limbs. The phenotypic overlap between different types of hereditary and acquired peripheral neuropathies indicates that similar pathophysiological processes are at play. Many downstream pathways in peripheral neurons, such...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Histone Deacetylase Inhibitors Research
Share to Peptidase Inhibition and Analysis
Share to Signaling Pathways in Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30360671
DOI: 10.1080/14728222.2018.1541235

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HDAC6 as a potential therapeutic target for peripheral nerve disordersPMID 30360671Read ↗

HDAC6: A Key Link Between Mitochondria and Development of Peripheral NeuropathySemantic proximity Read ↗

HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?Semantic proximity Read ↗

The Complex Clinical and Genetic Landscape of Hereditary Peripheral Neuropathy.Semantic proximity Read ↗

HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease.Semantic proximity Read ↗

Treatment of Charcot-Marie-Tooth neuropathies.Semantic proximity Read ↗

Matrix metalloproteinases, purinergic signaling, and epigenetics, hubs in the spinal neuroglial network following nerve injury.Semantic proximity Read ↗

Neuropathy target esterase: An essential enzyme for neural development and axonal maintenanceSemantic proximity Read ↗

Bicyclic-Capped Histone Deacetylase 6 Inhibitors with Improved Activity in a Model of Axonal Charcot-Marie-Tooth Disease.Semantic proximity Read ↗

Peripheral Neuropathy: A Phenotype-Driven Review for Diagnosis and Management.Semantic proximity Read ↗

Pyruvate kinase activates SARM1 to exacerbate axonal degeneration in diabetic peripheral neuropathySemantic proximity Read ↗

A Therapeutic Perspective of HDAC8 in Different Diseases: An Overview of Selective InhibitorsSemantic proximity Read ↗

Charcot-Marie-Tooth disease: emerging mechanisms and therapies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.